Cantex Pharmaceuticals, Inc.

Insider Reports History

Entity
Company
Location
1792 Bell Tower Lane, Suite 222, Weston, FL
Signature
/s/ Juan F. Rodriguez, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cantex Pharmaceuticals, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHIMERIX INC 10%+ Owner Common Stock, par value $0.001 3.5M $3.34M $0.96 Sep 14, 2021 Direct

Insider Reports Filed by Cantex Pharmaceuticals, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CMRX CHIMERIX INC Sep 14, 2021 1 -$37.4M 4 Sep 16, 2021 10%+ Owner